198
1.
Nussbaum SR, Thompson AR, Hutcheson KA, Gaz RD, Wang CA. Intraoperative
199
measurement of parathyroid hormone in the surgical management of
200
hyperparathyroidism. Surgery. 1988;104(6):1121-1127.
201
2.
Kunstman JW, Kirsch JD, Mahajan A, Udelsman R. Clinical review: Parathyroid
202
localization and implications for clinical management. The Journal of Clinical
203
Endocrinology and Metabolism. 2013;98(3):902-912.
204
3.
Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, Doherty GM, Herrera
205
MF, Pasieka JL, Perrier ND, Silverberg SJ, Solorzano CC, Sturgeon C, Tublin ME,
206
Udelsman R, Carty SE. The American Association of Endocrine Surgeons Guidelines
207
for Definitive Management of Primary Hyperparathyroidism. JAMA Surg.
208
2016;151(10):959-968.
209
4.
Barczynski M, Konturek A, Hubalewska-Dydejczyk A, Cichon S, Nowak W.
210
Evaluation of Halle, Miami, Rome, and Vienna intraoperative iPTH assay criteria in
211
guiding minimally invasive parathyroidectomy. Langenbeck's archives of surgery.
212
2009;394(5):843-849.
213
5.
Utilization. Surg Oncol Clin N Am. 2016;25(1):91-101.
214
215
Patel KN, Caso R. Intraoperative Parathyroid Hormone Monitoring: Optimal
6.
Chen R, Oh HB, Parameswaran R, Gorelik A, Miller JA. Practice Patterns in
14
216
Parathyroid Surgery: A Survey of Asia-Pacific Parathyroid Surgeons. World journal of
217
surgery. 2019;43(8):1964-1971.
218
7.
Med. 2011;135(2):211-214.
219
220
8.
9.
Kikumori T, Inaishi T, Miyajima N, Shibata M, Takeuchi D. Robust, quick, and
convenient intraoperative method to differentiate parathyroid tissue. Surgery. 2019.
223
224
Isono H, Shoumura S, Emura S. Ultrastructure of the parathyroid gland. Histol
Histopathol. 1990;5(1):95-112.
221
222
Hitchcock CL. The future of telepathology for the developing world. Arch Pathol Lab
10.
Kikumori T. Data from: Supplementary video for "Measurement of AST to LD ratio
225
in parathyroid tissue suspension can precisely differentiate hyperfunctioning
226
parathyroid". Figshare 2020. Deposited March, 29, 2020.
227
http://doi.org/10.6084/m9.figshare.12044835.
228
11.
White WM, Tearney GJ, Pilch BZ, Fabian RL, Anderson RR, Gaz RD. A novel,
229
noninvasive imaging technique for intraoperative assessment of parathyroid glands:
230
confocal reflectance microscopy. Surgery. 2000;128(6):1088-1100; discussion
231
1100-1081.
232
12.
Kwak JY, Kim EK, Moon HJ, Kim MJ, Ahn SS, Son EJ, Sohn YM. Parathyroid
233
incidentalomas detected on routine ultrasound-directed fine-needle aspiration biopsy
234
in patients referred for thyroid nodules and the role of parathyroid hormone analysis
15
in the samples. Thyroid. 2009;19(7):743-748.
235
236
13.
Perrier ND, Ituarte P, Kikuchi S, Siperstein AE, Duh QY, Clark OH, Gielow R,
237
Hamill T. Intraoperative parathyroid aspiration and parathyroid hormone assay as an
238
alternative to frozen section for tissue identification. World journal of surgery.
239
2000;24(11):1319-1322.
16
240
Figure legends
241
Figure 1
242
Box plot showing logarithmically transformed AST/LD ratios in suspensions of various
243
tissues. The box plot shows upper and lower quartiles. The median is represented by a bold
244
line within the boxes. The whiskers extend from each quartile to the minimum or maximum,
245
and outliers are indicated by dots. The median for each of the tissue types is indicated at the
246
bottom of the figure. Thyroid cancer: local recurrence, metastatic lymph nodes, and primary
247
tumor; miscellaneous tissues: median cervical cyst, connective tissue, and thymus. The bold
248
horizontal broken line indicates the optimal threshold value for distinguishing HPT from
249
other tissues (0.36).
250
Figure 2
251
Scatter plot showing the correlation between the AST/LD ratio and intact PTH in suspensions
252
of HPT. The data were logarithmically transformed. The closed square indicates a malignant
253
case. The closed circle in parentheses indicates a case that was off the scale. The bold vertical
254
line indicates the optimal threshold value for distinguishing HPT from other tissues (0.36).
255
The correlation coefficient (r) is indicated in the graph. ns: not significant.
Table 1
Table 1
Table 1
Patients’ characteristics, surgical indications, and specimen information.
Sex (M : F )
Age (mean, (range))
6:16
57y, (32-83)
Surgical indication
Primary hyperparathyroidism due to single adenoma
Primary hyperparathyroidism due to double adenomas
Multiple endocrine neoplasia type 1
Parathyroid carcinoma
Total
14
22
Analyzed specimens of hyperfunctioning parathyroid tissue
Adenoma
Hyperplasia
Carcinoma
Total
16
10
27
Previously reported specimens (for comparison)
Normal parathyroid gland
Thyroid cancer
Normal lymph node
Normal thyroid
Adipose tissue
43
19
13
10
Miscellaneous
Total
Median cervical cyst
Connective tissue
Thymus
94
Table 2
Table 2
Hyperfuctioning parathyroid tissue (hyperplasia)
age sex
37 F
66 F
43 F
44 M
54 F*
32 M**
Surgical Indication
MEN1
MEN1
MEN1
MEN1
MEN1
MEN1
Surgical procedure
total
total
total
total
total
subtotal
AST (IU/L)
99
360
138
81
566
168
559
236
107
107
LD (IU/L)
238
342
239
155
511
251
675
250
168
97
15,395
320,625
152,125
33,975
49,550
130,300
53,460
120,975
43,725
19,090
0.42
1.05
0.58
0.52
1.11
0.67
0.83
0.94
0.64
1.1
intact PTH (pg/mL)
AST/LD
Hyperfuctioning parathyroid tissue (adenoma)
age sex
63 F
63 M
53 M
67 F
40 M
39 F
50 F
66 F
73 F
50 F
Surgical Indication
SA
SA
SA
SA
SA
SA
SA
SA
SA
DA
AST (IU/L)
114
704
95
71
223
42
243
25
198
215
425
LD (IU/L)
180
1,982
78
375
108
221
48
299
273
366
23,190
***
13,760
13,125
102,825
56,988
160,875
38,412
78,850
205,875
390,500
0.63
0.36
1.22
14.2
0.59
0.39
1.1
0.52
0.66
0.79
1.16
intact PTH (pg/mL)
AST/LD
Hyperfuctioning parathyroid tissue (adenoma)
age sex
Hyperfuctioning parathyroid tissue (carcinoma)
75 F
60 M
72 F
75 F
83F
40 F
Surgical Indication
SA
SA
SA
SA
SA
ParaCa
AST (IU/L)
69
215
139
41
21
126
LD (IU/L)
81
265
105
49
46
583
60,875
14,975
157,500
61,013
25,700
30,850
0.85
0.81
1.32
0.84
0.46
0.22
intact PTH (pg/mL)
AST/LD
Table 2
Table 2.
Patients’ age, sex, surgical indications, surgical procedures, AST levels, LD levels, intact PTH values, and the AST/LD ratio.
Data are shown for each final pathological diagnosis.
MEN1: multiple endocrine neoplasia type 1; SA: single adenoma; DA: double adenoma; ParaCa: parathyroid cancer.
Total: total parathyroidectomy followed by autotransplantation; subtotal: subtotal parathyroidectomy.
*This patient had multiple enlarged parathyroid glands. Therefore, multiple specimens were available for analysis using a remnant of
autotransplantation.
**Subtotal parathyroidectomy was performed because of multiple liver metastases of a pancreatic neuroendocrine tumor.
*** off-scale high.
figure 1
10
0.36
AST/LD
0.1
0.01
Hyperfunctioning Normal
parathyroid
parathyroid
tissue (benign)
tissue
median
0.8
0.43
Parathyroid
carcinoma
Normal
thyroid
Adipose
tissue
Normal
lymph node
Thyroid
cancer
Miscellaneous
0.22
0.12
0.1
0.07
0.07
0.06
Figure 1
figure 2
()
intact
PTH
(pg/mL)
100,000
r=-0.13, ns
10,000
0.1
0.36
AST/LD
10
Figure 2
...